Loading
Alkem Laboratories Limited Stock: price and insider trades · India
1 insider bought shares over the last 90 days, the latest by HDFC Mutual Fund, filed 10 Sept 2026.
Insider Decl.
24
Thresholds
n/a
Buy Volume
€306,892
5 ops. · all time
Sell Volume
€3M
9 ops. · all time
Who traded when
BuySaleHDFC Mutual Fund1 buy
Since the insiders bought
- -3.8%Entry ₹3,265.40 · Close at T+365 ₹3,141.50
- -0.2%Entry ₹3,277.95 · Close at T+365 ₹3,272.60
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Alkem Laboratories Limited Buy (bullish), based on 20 analysts. Average price target: ₹6,002.55.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 7,231 of 26,280 companies
62.8
score / 100
Value45
Quality81
FCF yld2.3%
Earn yld3.9%
EV/EBITDA18.2x
ROE18%
Gross mgn64%
Net mgn16%
Debt/EBITDA0.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
₹5,017.50
Analyst consensus
20 analystsBuy
₹4,590.00Target ₹6,002.55(+20%)₹6,850.00
Income statement
Revenue₹145.3B
Gross profit₹93.3B64% margin
EBITDA₹33.7B23% margin
Net income₹23B14.3% margin
Valuation
PER (trailing)27.8x
PER (forward)22.4x
P/Book4.3x
Beta0.29
Balance sheet & cash
Market cap₹599.9B
Total debt₹20.5B
Free Cash Flow₹13.5B
Debt / Equity14%
Profitability & ownership
ROE17.6%
ROA8.5%
% insiders61.4%
% institutions28.4%
Last declaration on 10 September 2026
Declarations24 total
25,019 shares-MarketSEBI:f13693b6a0f153db00108b70368c2670e14fb633
Canonical exit: 9 Dec 2026 (T+90)
25,000 shares@ ₹3,609.423241.8% of flowEquity SharesSEBI:80018716e930583a88c94874d2a41855c92ea6f9
3,357 shares@ ₹3,184.949167.4% of flowEquity SharesSEBI:adff18f5db6e1c481125829a579430b77f842832
Canonical exit: 2 Jun 2022 (T+90)
1,643 shares@ ₹3,158.041432.6% of flowEquity SharesSEBI:3e5f4526c58c73612b94272eb24363ae0c98a2ed
Canonical exit: 5 Jun 2022 (T+90)
1,050 shares@ ₹3,275.0034.3% of flowEquity SharesSEBI:f909c85b4e2bd83098ef7590a6e1ddfd256f296f
Canonical exit: 24 May 2022 (T+90)
2,000 shares@ ₹3,295.870565.7% of flowEquity SharesSEBI:00529b8959829a03f602fbee682f41c0815e7886
Canonical exit: 22 May 2022 (T+90)
2,000 shares@ ₹3,491.16653.2% of flowEquity SharesSEBI:89bd0680b1d5f41c8f1e14ef1bbde7128dc4c701
2,000 shares@ ₹3,437.31353.1% of flowEquity SharesSEBI:25d5c5c2dee1743f259a2ae28c6d8e7c6ce5251c
5,000 shares@ ₹3,435.82627.8% of flowEquity SharesSEBI:876a76092020ebdbd188b41ca28f5e06a52ab721
2,000,000 sharesEquity SharesSEBI:95e78f689c921e718501233a1ca86f548bc0372d
5,000 shares@ ₹3,572.55248.2% of flowEquity SharesSEBI:53ea3efe51d01a05baf8e31464bb741f58f92ea9
50,266 sharesEquity SharesSEBI:651f142fb6ad40523fb20dc4a3d313eb7dd095c1
50,267 sharesEquity SharesSEBI:998d06a31497212aab4c8b503fb11999f4254ec9
4,000 shares@ ₹3,924.0147.0% of flowEquity SharesSEBI:3ac553342760c674be0066da22cf64de3125d970
4,000 shares@ ₹3,918.03157.0% of flowEquity SharesSEBI:4e8269ec35a2ae4955cf6342692f402d36c256d8
4,789 shares@ ₹3,864.13538.3% of flowEquity SharesSEBI:0712af992678ee0b1650563a46c544b7fe05d141
1,355,769 sharesEquity SharesSEBI:a7c55908db576f5387f58c0b0671bfdc8cea0ed6
1,355,769 sharesEquity SharesSEBI:54df62112a0a9b8d4d13c7dd399da9bfcf9d7dbb
250 sharesEquity SharesSEBI:51ad8af74d18b29db17ef464a967cac5d0f31075
250 sharesEquity SharesSEBI:829a48e5c990c31505591578100cc7abce574981
2,065,556 sharesEquity SharesSEBI:98a4f95dcd90e76ed5df66bcb732210d5278861f
13,251 sharesEquity SharesSEBI:0d74c1a4e7d6cf8af301cdb7be27f8cd5a170f7a
2,052,305 sharesEquity SharesSEBI:dc76b6aa7377f94702fb785fe015da685a67ebda
10,000 shares@ ₹3,098.96140.0056% mcap13.5% of flowEquity SharesSEBI:0c16f021b9ef6137d948747a1c4ab5c794340bcb
24 of 24 declarations
About Alkem Laboratories Limited
Deepak Kumar Singh filed 9 of the 24 filings at Alkem Laboratories Limited, and all are sales: the largest, EUR 1,077,684 on March 28, 2022, ahead of EUR 348,044 on June 10, 2021 and EUR 213,589 on September 17, 2021. In all, the 9 sales in the file add up to EUR 2,575,387, with a median of EUR 200,858.
Alkem, an Indian Healthcare company listed on the Bombay Stock Exchange and valued at INR 599.9 billion, has 12 filers, who hold 61.4% of the capital. The 5 purchases, 4 of them with an amount, weigh EUR 306,892 (median EUR 69,597): Mritunjay Kumar Singh bought EUR 127,062 on March 4, 2022, then EUR 61,320 on March 7, and Dhananjay and Madhurima Singh Trust EUR 77,875 on February 21, 2022.
Read moreShow less
The year 2021 counts 18 filings, against 5 in 2022 and one in 2026, the latter being a purchase. The operations run from June 10, 2021 to September 10, 2026, published a median of 1 day later.
